Drug intelligence / Profile preview

SARS-CoV-2 technology

Development stage: Preclinical
Lead developer: Fluart Innovative Vaccines
Modality: Vaccines & Immunotherapeutics
Administration: Intramuscular, Mucosal, Intradermal, Intranasal, Oral

Overview

SARS-CoV-2 technology is a vaccine candidate being developed by Fluart Innovative Vaccines for the prevention of COVID-19. Currently in the preclinical proof-of-concept stage, the project leverages Fluart's expertise in viral vaccine development to target the SARS-CoV-2 virus. Fluart Innovative Vaccines, a Hungarian biotechnology company, is primarily known for its influenza vaccine products, including a whole-virion inactivated vaccine. While the specific platform for this SARS-CoV-2 candidate—such as inactivated, subunit, or viral vector—is not explicitly detailed in the company's pipeline, the project represents an expansion of Fluart's R&D portfolio into addressing emerging viral threats beyond its core influenza business.

Other names: SARS-CoV-2 technologySARS-CoV2 technologySARS-CoV 2 technologyFluart COVID-19 vaccineFluart Innovative Vaccines-SARS-CoV-2-vaccine technology-COVID-19

Beyond the preview

Go deeper on SARS-CoV-2 technology.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SARS-CoV-2 technology.

Explore the full profile